Our 2D/3D Cytotoxicity Assays are conducted on over 150 tumor-derived cell lines, with testing conditions optimized for specific agents and cell lines.
The BIOENSIS 3D cellular cytotoxicity-screening platform improves early-stage drug development decisions by accurately measuring the efficacy of your novel anti-cancer agent. Our 3D culture protocols offer exceptional flexibility in testing conditions, allowing for effortless customization of assays to meet your specific requirements.
Key assay features:
• 150+ cell lines available for testing
• Compounds tested in quadruplicate at nine concentrations
• Cell viability determined by ATP measurement
• Precision IC50, EC50, and GI50 results
• Multiple endpoints available to meet your needs (proliferation, apoptosis, cell signaling)
• Flexible testing protocols
• Combination screening available
• Available in 2D and 3D cultures
Please contact us to discuss your study and an up to date list of available cell lines
info@bioensis.com
